content top

Intravitreal Preservative-free Triamcinolone (MaQaid) for Chromovitrectomy

This film is to introduce preservative-free triamcinolone acetonide (MaQaid, Wakamoto Pharmaceutical Co., Ltd., Tokyo, Japan) assisted membranectomy for epiretinal membrane (ERM) and macular hole (MH) surgery. Standardized 25-gauge trans pars planavitrectomy (TPPV) and membranectomy ± internal limiting membrane (ILM) peeling was performed by a single surgeon in eyes with ERM; ILM peeling was not attempted unless the ILM was peeled with...

Read More

Reverse Triamcinolone Staining for ILM Peeling

In this video, we will see how reverse triamcinolone acetonide (TA) staining can be used to make internal limiting membrane (ILM) peeling, easier and safer. The ILM is the layer that borders the vitreous body and the retina, and also the basement membrane for the muller cells. It functions as the foothold for cell reproduction and is involved in macular diseases, such as epiretinal membrane or vitreo- macular traction. The expected...

Read More

ILM Peeling with and Without Adjunctive Triamcinolone – Did the ME Study Make a Difference ?

Background: Before the EVRTS-Meeting in Dresden 2012 we always used adjunctive Triamcinolone at the end of epiretinal membrane surgery with ILM-peeling, thinking, that this would reduce postoperative macular edema. However, in reaction to the results of the ME-Study, published in Dresden in 2012 which suggest that cortisone hinders the edema-lowering effect of ILM-peeling, we discontinued the use of adjunctive Triamcinolone in all cases...

Read More

Duration of Effect of Triamcinolone Intravitreal Injection in Previously Vitrectomized Eyes

Media not available due to technical recording problems. EVRS is very sorry for the inconvenience.   Advantages: Triamcinolone acetonide is a corticosteroid used in the treatment of macular edema of different etiologies. To the best of our knowledge, the duration of effect of this therapy has not been described in previously vitrectomized eyes. Methods: Retrospective, descriptive, non-comparative study including eyes that underwent 23G...

Read More

Dexamethasone Implant in Pseudophakic CME

SCIENTIFIC POSTER_Jesus Zarallo Gallardo Pseudophakic cystoid macular edema is a condition presenting after complicated or even uncomplicated cataract surgery. Although it can be subclinic in many cases and self-limited, sometimes it is a recalcitrant disease that limits the results of an otherwise perfect surgery. The therapeutical options for this edema include oral acetazolamide, sub-Tenon corticosteroid injection, intravitreal...

Read More

Intravitreal Dexamethasone Implant for Exudative RD Secondary to Primary Breast Cancer

Purpose: To report the effectiveness of intravitreal dexamethasone implant (Ozurdex) in treating exudative retinal detachement secondary to primary breast cancer. Method: A women with 45 years old with serous retinal detachment and a current history of metastasis in lungs and due to breast cancer was treated with two dexamethasone implants. Best corrected visual acuity, ophthalmoscopy and OCT were performed before and after...

Read More

Dexamethasone Implant in a Pregnant Woman for the Treatment of ME in CRVO

Poster Jesus Zarallo Gallardo Introduction: There are several retinal diseases that may worsen or alter during pregnancy as a result of hematologic, hormonal, metabolic, cardiovascular, and immunologic changes. Although normal pregnancy and its hypercoagulable state may induce retinal vein occlusion, hereditary or acquired changes in hemostatic factors increase the risk of thromboembolic events. The risk of venous thromboembolism in...

Read More

Intravitreal Triamcinolone Versus Bevacizumab for Treatment of Subretinal Fluid in Diabetic Retinopathy

Poster V. Levent Karabas Purpose: To evaluate the efficacy of intravitreal triamcinolone acetonite (IVT) injection versus intravitreal bevacizumab (IVB) injection in the management of subretinal fluid in patients with diabetic retinopathy. Methods: Forty-seven patient affected by diabetic macular edema with subretinal fluid were included. Patients were assigned randomly to two groups. IVT group, patients who received 4mg/0.1ml...

Read More

Retinal Detachment After Dexamethasone Intravitreal Implant

Poster 2 Israel Gomez Sanchez Advantages: To evaluate the clinical findings and treatment outcomes in a patient with Branch retinal vein occlusion. Methods: To report a case of BRVO in a 60 years old patient, hypertensive who was treated, two days from diagnosis, with PPV and liberation of adventitia, with success. Two weeks afterwards developed a macular oedema, which was treated with a Dexamethasone intravitreal implant (Ozurdex ®)....

Read More

Twenty-four Hours Clinical and Tomographical Changes After Dexamethasone Intravitreal Administration

Poster Barbara Delas Objective: To analyse the structural and functional changes in patients with macular oedema secondary to retinal vein occlusion and non-infectious posterior uveitis, twenty-four hours after the injection of a dexamethasone intravitreal implant. Method: 6 eyes of 6 patients were analysed (3 branch retinal vein occlusion, 2 central retinal vein occlusion and 1 case of non-infectious uveitis). For each patient, age, sex,...

Read More

Comparison Between Diclofenac & Dexamethasone on Blood-aqueous Barrier Breakdown

Poster 1 Salim Ben Yahia Advantages: To compare the effect of topical diclofenac and topical dexamethasone on blood-aqueous barrier breakdown following posterior segment surgery. Methods: The study included 50 eyes treated with posterior segment surgery for rhegmatogenous retinal detachment, intravitreal haemorrhage, epiretinal membrane, or macular hole. Patients underwent scleral buckling, pneumatic retinopexy, or pars plana vitrectomy...

Read More

Combined Intravitreal Anti-VEGF & Subtenon Corticosteroids in AMD to Reduce ME Recurrence

Purpose:  To evaluate combined treatment of Anti-VEGF & subtenon corticosteroids for recurrent macular edema (ME) associated to choroidal neovascularization (CNV) due to age related macular degeneration (AMD). Material & Methods: Cases of CNV in AMD were included in this retrospective study. All types of CNV could be included (classic, minimally classic, occult, PEDs) Results: This combined therapy seemed to decrease ME...

Read More

Ozurdex in Vitrectomized Eyes

Purpose: To define the effectiveness of dexamethasone implant in macular edema in vitrectomized eyes. Methods: Two eyes of 2 patients, (one with diabetic macular edema, the other with macular edema secondary to central retinal vein occlusion) who had been treated with intravitreal anti-VEGFs, triamcinolone, laser photocoagulations and vitrectomy + ILM peeling earlier without any response, were treated with IV dexamethasone implant as a...

Read More

Intravitreal Implant of Dexamethasone for the Treatment of Refractory Vitrectomy Induced Cystoid Macular Edema

Advantages: Surgically induced cystoid macular edema (SICME) is a complication that can occur after various types of intra-ocular surgeries. SICME could be seen following glaucoma surgery, iridotomies, penetrating keratoplasty, scleral buckling, anterior vitrectomy and pars plana vitrectomy (PPV). The incidence of SICME is usually higher in more complicated procedure (combined procedures). There are several articles documenting that SICME...

Read More

Coats’ Disease: Intravitreal Triamcinolone with or Without Transscleral Drainage: The Way to Go!

Purpose: To evaluate the role of intravitreal Triamcinolone (TA) in the early management of Coats’ disease with or without trans-scleral drainage. Methods: Retrospective, interventional case series. Fifteen consecutive cases with Coats’ disease were managed with 4mg/0.1ml intravitreal Triamcinolone injection on presentation and were followed up for a minimum duration of one year. Additional management strategies included...

Read More

The Effectiveness and Safety of Triamcinolone Injections in DME

Advantages: Intravitreal triamcinolone injections turned out to be effective in reducing macular edema and improving vision in refractory DME after a laser treatment or even as an initial treatment. The steroid-related adverse events, e.g. cataract and elevated intraocular pressure, should be weighed against the benefits of the treatment. Methods: Twenty-mg triamcinolone acetonide intravitreal injections (IVTA) were applied to 110 DME...

Read More

Effectivity of Intravitreal Triamcinolone Injections for Diabetic Cystoid Macular Edema

Persistent diffuse macular edema (ME) or cystoid ME is a result of chronic inflammation with the generalized breakdown of the inner blood retinal barrier and fluid accumulation, primarily in the outer plexiform layer. This process is characterized by the development of hard exudates and progressively lost of vision. Triamcinolone acetonide is the most effective anti-inflammatory agent. After injection into the vitreous cavity...

Read More

Comparison of Endovitreal Triamcinolone with Betamethasone in DME

Advantages: Use of intravitreal injection of crystalline corticosteroids- bethamethasone and triamcinole dose of 4 mg in 0.1 ml allows to improve visual acuity and restore adequate morphological retinal thickness in patients with diffuse diabetic macular edema. Methods: Comparison of efficacy and safety of intravitreal injection of 4 mg (0.1 mL) triamcinolon (36 patients – 40 eyes) and 4 mg (0.1 mL) bethamethasone (60 patients...

Read More

Fluocinolone Acetonide Implants for the Treatment of Chronic DME

Advantages: Given the chronic nature of diabetic macular edema (DME), an implant (ILUVIEN®) that releases a continuous, submicrogram daily dose of fluocinolone acetonide (FAc) could fill an unmet need for continuous long-term therapy. Methods: The Fluocinolone Acetonide in Diabetic Macular Edema (FAME) study consisted of 2 randomized, prospective, multicenter, double-masked, sham-controlled, parallel-group phase 3 trials enrolling...

Read More

Effectiveness of Combined Betamethasone and Laser Coagulation for DME

Advantages: Combined treatment of diffuse diabetic macular edema using intravitreal injection of bethamethasone and laser coagulation is effective in improving visual acuity and restoration of the morphofunctional state of the retina. Methods: Intravitreal injection 4 mg (0.1 ml) of bethamethasone combined with laser coagulation was conducted in 33 patients (33 eyes) with diffused diabetic macular edema. Patients were divided into 2...

Read More

Evaluating Adjunctive Surgery to Ozurdex for the Treatment Macular Edema Following RVO

Ozurdex®, a dexamethasone (DEX) intravitreal implant, has been shown in randomized controlled trials to reduce macular edema and improve visual acuity in patients with either branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO). However, repeated injections are usually necessary, particularly for CRVO patients. And the long-term adverse events, including the incidence of cataract and glaucoma, are still...

Read More

Combined Treatment with Sub-tenon Injection of Triamcinolone and Intravitreal Anti-VEGF Injection in Refractory Neovascular ARMD

Advantages: Combined treatment with sub-Tenon’s injection of triamcinolone and intravitreal anti-VEGF injection has beneficial effect in improving visual acuity and anatomic outcomes in refractory neovascular AMD patients. Methods: Seven eyes of 7 patients with refractory neovascular age-related macular degeneration (AMD) secondary to polypoidal choroidal vasculopathy (PCV) were enrolled. Refractory PCV was defined as no response of...

Read More

Comparison of Grid Laser, Intravitreal Triamcinolone, and Intravitreal Bevacizumab for the Treatment of Diffuse Diabetic Macular Edema

http://www.evrs.eu/medias/2010/congress/Non-Proliferative-Diabetic-Maculopathies.flv Gungor Sobaci, Cuneyt Erdurman, A. Hakan Durukan (Ankara, Turkey) Purpose: Controversy exists in the literature regarding the most appropriate method of treatment in diabetic macular edema. We aimed to find out the current best care for selected group of patients who had untreated, acute, and diffuse diabetic macular edema. Methods: Patients with acute...

Read More

Intravitreal Injections of Triamcinolone vs Bevacizumab vs Sham Treatment during Phacoemulsification on Diabetic Macular Edema

http://www.evrs.eu/medias/2010/congress/Non-Proliferative-Diabetic-Maculopathies.flv Siamak Moradian, Amir Faramarz, Qiumars Heidari, Masoud Salehipoor, Mohammad Mohammadzadeh (Tehran, Iran) Advantages: To compare the results of IVT vs IVB vs sham injections at the end of phacoemulsification (PE) on diabetic macular edema (DME). Methods: In a RCT 88 diabetic patients with at least moderate NPDR were undergone one of the 3 injections, IVT...

Read More

Using of a New Dye, Vitreocontrast for Vitreous Body Visualization

Nataliya M. Kislicyna, S.V. Novikov, S.V. Belikova (Moscow, Russia) Advantages: One of the current questions in vitreous surgery is the visualization of vitreous body and the identification of semi-transparent epiretinal membranes and internal limiting membrane. Peyman was the first to report on the use of triamcinolone acetonide as an aid to visualize the vitreous and posterior hyaloid during vitrectomy. The water- insoluble triamcinolone...

Read More

Three-Intravitreal Bevacizumab vs Two-Intravitreal Triamcinolone Injections in Retinal Vein Occlusion

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Alireza Ramezani, Morteza Entezari, Siamak Moradian, Hamed Esfandiari, Babak Dehsarvi, Masoud Soheilian, Hamid Ahmadieh, Mehdi Yaseri (Tehran, Iran) Advantages: Repeated intravitreal injections of bevacizumab (IVB) are more effective than repeated intravitreal injections of triamcinolone (IVT) in acute retinal vein occlusion...

Read More

Intravitreal Triamcinolone and Bevacizumab Injection for Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion

Kubilhan Elmas, Özgür Bilen, Ali Altýnsoy (Ankara, Turkey) Purpose: To evaluate the efficacy of intravitreal triamcinolone injection in eyes with macular edema due to branch retinal vein occlusion (BRVO) over a 1-year period. Methods: The authors performed a retrospective chart review of 18 eyes of 18 patients (mean age 71 years) who underwent intravitreal injections with 2 mg triamcinolone acetonide and 1,25 mg bevacizumab for macular...

Read More

Comparison of Intravitreal Triamcinolone and Combined Triamcinolone-Bevacizumab Injection as Adjunctive Treatment to Grid Laser Photocoagulation for Diffuse Diabetic Macular Edema

Osman Çekiç, M. Selim Kocabora, Nilay Kandemir (Istanbul, Turkey) Advantages: To assess the effectiveness of intravitreal triamcinolone and combined triamcinolone-bevacizumab injection as adjunctive treatment to grid laser for diffuse diabetic macular edema. Methods: Sixty-nine eyes of 69 patients (29 male, 40 female) with diffuse diabetic macular edema were intravitreally injected either with 4mg/0.1ml triamcinolone (n = 29) or...

Read More

Intravitreal Triamcinolone Acetonide for Macular Edema Owing to Retinal Vein Occlusion

Ozgür Bilen, Kubilhan Elmas, Ali Altýnsoy (Ankara, Turkey) Purpose: To assess the long-term safety and efficacy of intravitreal triamcinolone acetonide injection in the management of macular edema caused by branch retinal vein occlusion. Methods: This retrospective case series included 11 patients (11 eyes) with retinal vein occlusion and macular edema. They received an intravitreal injection of 4 mg triamcinolone acetonide. Follow-up...

Read More

Triamcinolone Acetonide-Assisted ILM Peeling in a Case of Myopic Macular Retinal Detachment

http://www.evrs.eu/medias/2010/videos/MohamedElDeeb_2_VP6_768K.flv Mohamed El-Deeb (Cairo, Egypt) Advantages: A lot of dyes are used to help ILM peeling. All of them carry the risk of retinal toxicity. This video shows that triamcinolone acetonide (which is very safe) can be used effectively as an alternative tool to the commonly used dyes. Methods: After doing core vitrectomy, non-preserved triamcinolone acetonide is injected in the...

Read More

Efficacy of Intravitreal Triamcinolone Acetonide Injection in Treating Refractory Proliferative Diabetic Retinopathy

http://www.evrs.eu/medias/2010/congress/Proliferative-Diabetic-Retinopathy.flv Arwa Azmeh, Judi Abdin (Damascus, Syria) Advantages: To evaluate the efficacy of intravitreal triamcinolone acetonide injection (IVT) in causing regression of new vessels activity in proliferative diabetic retinopathy (PDR) refractory to pan retinal photocoagulation (PRP). Methods: 11 eyes of 10 patients with type 2 diabetes and active PDR refractory to PRP...

Read More

Management of Lipid Exudates in Coats’ Disease by Adjuvant Intravitreal Triamcinolone: Effects and Complications

http://www.evrs.eu/medias/2010/congress/Vascular-Pathologies-in-Young-Patients.flv Ihab Saad Othman, Magdy Moussa, Manal Bouhaimed (Giza, Egypt) Advantages: Coats disease is associated with vascular leaky telangiectatic vessels. Intravitreal triamcinolone injection modulates leaking vessels and is associated with subretinal fluid resorption that can be followed by laser peripheral photoablation. Methods: Retrospective, interventional case...

Read More

Comparison of Effect of Cataract Surgery with Bevacizumab Alone and Combined with Intravitreal Triamcinolone on Progression of Diabetic Retinopathy

Authors: Elmas Kubilhan, Bilen Özgür, Arsen Akýncý, Ersel Özkýlýç, Ali Altýnsoy, Ankara, Turkey Advantages / Purpose: To study the effect of Cataract Surgery with Bevacizumab alone and Combined with Intravitreal triamcinolone Injection on Progression of Diabetic Retinopathy. Setting: Kudret Eye Hospital, Ankara. Methods: Cataract surgery with phacoemulsification was performed in 52 eyes of 44 patients who had diabetic retinopathy....

Read More

Effects of Anti-VEGF Therapy versus Triamcinolone Intravitreal Injection on Non Ischemin Macular Edema of BRVO

Authors: Dong Hyun Jee, Sang Hee Doh, Suwon City, Kyoungki Province, South Korea Advantages: Effects of intrvitreal ranibizumab injection are more efficient than intravitreal triamcinolone injection on non-ischemic macular edema of BRVO. Methods: In a prospective randomised clinical trial, 50 eyes of 50 patients with non-ischemic macular edema of BRVO were included. Eligible eyes were assigned to 0.05mg ranibizumab(25 eyes) or 0.05cc...

Read More

The Comparison of Intravitreal Triamcinolone Acetonide (TA) Versus Avastin in Clinically Significant Macular Edema

Masih Hashemi, Roshanak Aliakbar Navahi, Khalil Ghasemi Falavarjani Advantages: In this double-blind randomized clinical trial study, we compared safety and effectiveness of intravitreal Triamcinolone Acetonide (TA) versus Avastin in patients with Clinically Significant Macular Edema (CSME). Methods: Four mg TA was injected in 28 eyes and 1.25 mg Avastin was injected in 23 eyes of patients with CSME. The visual acuity, intraocular pressure,...

Read More

Forecast of Visual Outcome of Intravitreal Kenalog Injection for Cystoid Macular Edema Caused by Retinal Veins Occlusion using OCT

I.A. Malov, O.A. Ulasevich, K.G. Naumov (State Institution “IRTC Eye Microsurgery” named after S.N. Fyodorov Ekaterinburg Branch, Ekaterinburg, Russia) Advantages: Forecast of visual outcome of intravitreal kenalog injection for cystoid macular edema(CME) caused by retinal veins occlusion using OCT provide a possibility to optimize indications for this procedure. Methods: A retrospective study of 13 patients (13 eyes) with cystoid...

Read More

Use of a New Type of Micronized Intravitreal Triamcinolone in Sutureless Vitrectomies

Marco Dal Vecchio, Valeria Russo, Sara Tonetti Advantages: IVT Micronized during sutureless vitrectomy allows observing the posterior Hyaloid and the vitreous base. In the video shows the differences between IVT Micronized and traditional Triamncinolone. Methods: The video shows the different uses of IVT micronized and the simultaneous injection of IVT and Triamcinolone. A preliminary report of cases of Sutureless Transconjunctival 25...

Read More

Retina Pigment Epithelial Tear Following Bevacizumab for Exudative Age-Related Macular Degeneration: An OCT Follow-Up

Osman Cekic, Mehmet Cakir, Omer F. Yilmaz Advantages: To report the usefulness of serial optical coherence tomography (OCT) follow-up of a case with retinal pigment epithelial (RPE) tear after intravitreal bevacizumab injection for serous pigment epithelial detachment (PED) from neovascular age-related macular degeneration (AMD). Methods: An 80-year-old woman underwent 1.25 mg intravitreal bevacizumab treatment for serous PED secondary to...

Read More

The Triple Therapy with PDT, Intravitreal Bevacizumab & Triamcinolone Injection for CNV due to AMD

Osman Cekic, Mehmet Cakir, Cengiz Alagoz, Nese Alagoz, Omer F. Yilmaz Advantages: To demonstrate the effectiveness of triple therapy in patients with subfoveal choroidal neovascular membrane (SCNM) related to age-related macular degeneration (AMD). Methods: Twenty-nine eyes of 26 patients (10 male, 16 female, mean age: 71.2 years) with SCNM that underwent triple therapy were evaluated retrospectively. Intravitreal injection of 2 mg...

Read More

New Therapeutic Approaches for Retinal Telangiectasia

Díez Villalba, Rosario, Mora de Oñate Javier, Rodriguez Márquez, María Trinidad, Izquierdo Vázquez Cristina, Alvarez Holgado Marta, Hita Antón César We present four cases of cystoid macular edema (CME) secondary to retinal telangiectasia: 1 case of Coats disease (adult form), 2 cases of unilateral macular telangiectasia (type 1) and 1 case of bilateral macular telangiectasia (type 2). Three cases were treated with intravitreal...

Read More

Intravitreal Bevacizumab Versus Intravitreal Triamcinolone For Diabetic Macular Edema With Severe Hard Exudates

Ben Yahia S, Jenzeri S, Hmidi K, Attia S, Zaouali S, Khairallah M Purpose: To compare response after intravitreal bevacizumab (IVB) or triamcinolone (IVT) in diabetic macular edema with severe hard exudates. Methods: Forty-eight eyes were randomly assigned to either IVB or IVT. Follow-up was > 6 months. Results: There was significant improvement in BCVA in the IVT group when compared with the IVB group (P= .04). Complete resolution of...

Read More

Combined Intravitreal Bevacizumab and Triamcinolone Acetonide for the Treatment of Acute Non-Arteritic Anterior Ischemic Optic Neuropathy

http://www.evrs.eu/medias/2008/congress/Combined-Intravitreal-Bevacizumab-and-Triamcinolone-Acetonide-for-the-Treatment-of-Acute-Non-Arteritic-Anterior-Ischemic-Optic%20Neuropathy.flv Morteza Entezari, Alireza Ramezani, Hassan Ghassemi, Alireza Naderi Ophthalmic Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, Iran. Purpose: To report the effect of combined intravitreal bevacizumab and triamcinolone acetonide...

Read More

Tritherapy Using Avastin, Visudyne and Triamcinolone as Treatment of Neovascular AMD

Guy l’Helgoualch, MD (Brest, France) PURPOSE: To check using Avastin in intravitreous injection reduces the surface and the thickness of the neovascular membrane. To check improving the effect of PDT and reducing the side effects increases the final visual acuity. To verify this protocol of tritherapy reduces the number of treatment during the period of follow-up. METHODS: The population of patients includes the same proportion of...

Read More

Avastin – It’s Not Just for Retina Anymore

Michael A. Singer, MD (San Antonio, TX), Rafael Lin Wong, (San Antonio, TX), Catherine Alderete, CMA (San Antonio, TX), Robin Hartman, BBA (San Antonio, TX) PURPOSE: To determine whether combination therapy of Avastin and Kenalog is useful in the treatment of corneal neovascularization. METHODS: A patient presenting with severe corneal neovascularization in both eyes and Hand Motion (HM) vision was given multiple treatments of Avastin, by...

Read More

Large Case Series of Different Types of CNV after Combination Treatment (PDT with Intravitreal Triamcinolone)

Albert J. Augustin, MD (Sulzfeld, Germany), Indre Offermann, MD (Karlsruhe, Germany), Stephan Puls, MD (Karlsruhe, Germany), Frank H.J. Koch, MD (Frankfurt am Main, Germany), Ursula Schmidt-Erfurth, MD (Vienna, Austria)* PURPOSE: To assess the treatment and outcome of patients with CNV treated with PDT combined with intravitreal triamcinolone (TA). METHODS: Patients (n? 307) suffering from CNV (76.2% subfoveal, 12.1% juxtafoveal, 11.7%...

Read More

Six-month Results of a Randomized, Double-masked, Controlled Trial of Intravitreal Triamcinolone as an Adjunct to Photodynamic Therapy in Predominantly Classic Neovascular Age-related Macular Degeneration: The Canadian RETINA Study

http://www.evrs.eu/medias/2006/congress/Six-month-Results-of-a-Randomized,-Double-masked,-Controlled-Trial-of-Intravitreal-Triamcinolone-as-an-Adjunct-to-Photodynamic-Therapy-in-Predominantly-Classic-Neovascular-Age-related-Macular-Degeneration:-The-Canadian-RETINA-Study.swf David Maberley, MD, FRCSC, MSc (Vancouver, Canada),* PURPOSE: To compare safety data and ETDRS visual acuity outcomes data for one-hundred subjects with predominantly...

Read More

Intravitreal Combination of Kenacort and Avastin (Ken-Av) for Choroidal Neovascular Age-related Macular Degeneration

Panos Stergiou, (Thessaloniki, Greece), Kostantinos Malamos, MD (Thessaloniki, Greece), Efstathios Dragiotis, MD (Thessaloniki, Greece), Anastasios Felekidis, MD (Thessaloniki, Greece), Tania Karagiani, MD (Thessaloniki, Greece), Stavros Dimitrakos, MD (Thessaloniki, Greece) PURPOSE: To investigate whether combined intravitreal use of triamcinolone (Kenacort) and bevacizumab (Avastin) can prolong the beneficial effect and reduce the need...

Read More

The Effect of Kenalog as Adjunctive Treatment to Visudyne in Minimally Classic and Occult Neovascular AMD: A Prospective, Randomized Clinical Trial

http://www.evrs.eu/medias/2006/congress/The-Effect-of-Kenalog-as-Adjunctive-Treatment-to-Visudyne-in-Minimally-Classic-and-Occult-Neovascular-AMD:-A-Prospective,-Randomized-Clinical-Trial.swf Tom Sheidow, MD, FRCS(C) (London, Canada), Varun Chaudhary, MD (London, Canada), Phil Hooper, MD, FRCSC (London, Canada), Alex Mao, MD (London, Canada) PURPOSE: To evaluate the mean change is ETDRS visual acuity score from baseline and the number of...

Read More

Combined Intravitreal Triamcinolone with Photodynamic Therapy for the Treatment of Choroidal Neovascularization in Age Related Macular Degeneration

http://www.evrs.eu/medias/2006/congress/Combined-Intravitreal-Triamcinolone-with-Photodynamic-Therapy-for-the-Treatment-of-Choroidal-Neovascularization-in-Age-Related-Macular-Degeneration.swf Catherine Favard, MD (Paris, France), Valerie Krivosic, MD (Paris, France), Lucie Machado, DO (Paris, France), Michael Assouline, MD, PhD (Paris, France), Catherine Francais, MD (Paris, France) PURPOSE: To determine whether photodynamic therapy (PDT)...

Read More

Triple Therapy: Photodynamic Therapy, Intravitreal Bevacizumab and Preservative Free Triamcinolone Acetonide for the Treatment of Exudative AMD

Arturo Santos, MD, PhD (Guadalajara, Mexico), Enrique A. Roig-Melo, MD PhD (Guadalajara, Mexico), Ramon Flores-Fuentes, MD (Guadalajara, Mexico), Juan C. Altamirano, MD (Guadalajara, Mexico) PURPOSE: To evaluate the feasibility and safety of the combination of photodynamic therapy with verteporfin (PDT), intravitreal Bevacizumab and preservative free Triamcinolone acetonide (PFTA) for the treatment of exudative AMD. METHODS: This is a...

Read More

Thermal Laser Photocoagulation Combined with Intravitreal Triamcinolone Injection for Treatment of Choroidal Neovascularization

Edwin H. Ryan, MD (Minneapolis, MN), Lejla Mutapcic, BS (Rochester, MN), Jose S. Pulido, MD (Chicago, IL) PURPOSE: To determine via a retrospective review of treated patients whether thermal laser photocoagulation combined with intravitreal triamcinolone (IVTA) can safely and effectively reduce the risk of neovascular membrane recurrence and vision loss in patients with choroidal neovascularization (CNV). METHODS: We conducted a...

Read More

Vitrectomy in Triple Therapy for Choroidal Neovascularization

Frank H.J. Koch, MD (Frankfurt am Main, Germany),* Albert J. Augustin, MD (Karlsruhe, Germany), Robert G. Josephberg, MD (Yonkers, NY),* K. Peter Luloh, (Sanford, FL),* Indre Offermann, MD (Karlsruhe, Germany), Shahrzad Ghozisad, MD (Frankfurt am Main, Germany), Joachim Puchta, MD (Frankfurt am Main,Germany), Pankaj Singh, MD (Frankfurt Am Main, Germany) PURPOSE: A treatment regimen that combines photodynamic therapy (PDT) with a core pars...

Read More

Recurrence of Choroidal Neovascularization 18 Months after Photodynamic Therapy with or without Kenalog in Age-related Macular Degeneration

Michael J. Potter, MD (Vancouver, Canada),* Shelagh M. Szabo, BSc (Vancouver, Canada) PURPOSE: To compare the incidence of recurrence of CNV at 18 months after treatment with photodynamic therapy (PDT) with verteporfin, and PDT plus intravitreal Kenalog (IVT), in patients with age-related macular degeneration. METHODS: This is a prospective study of consecutive patients treated with PDT alone, or PDT plus IVT at baseline. Final treatment...

Read More

Cannulation of the Suprachoroidal Space: Drug Delivery and Pharmacokinetics of Triamcinolone Acetonide and Bevacizumab

Timothy W. Olsen, MD (Minneapolis, MN),* Xiao Feng, MD (Minneapolis, MN),* Kathy Wabner, BA (Minneapolis, MN),* Stanley R. Conston, BS (Menlo Park, CA),* David H. Sierra, PhD (Menlo Park, CA),* Tom S. Chang, MD (Pasadena, CA),* Karl G. Csaky, MD PhD (Bethesda, MD), Morton E. Smith, MD (St. Louis, MO), J. Douglas Cameron, MD (Rochester, MN) PURPOSE: To describe a drug delivery system, surgical technique, safety and pharmacokinetics for...

Read More

Combined Photodynamic Therapy and Intravitreal Triamcinolone Injection for the Treatment of Subfoveal Choroidal Neovascularization

Noha Khater, (Cairo, Egypt), Hoda, MH Mostafa, MD (Cairo, Egypt), Mahmoud Soliman (Cairo, Egypt), Tamer Macky, MD (Cairo, Egypt) PURPOSE: To evaluate the outcomes of combined intravitreal triamcinolone (IVTA) and photodynamic therapy (PDT) in the treatment of subfoveal choroidal neovascularization (CNV) caused by age related macular degeneration (AMD) and myopia. METHODS: Fifteen eyes from 15 patients with subfoveal CNV caused by AMD (n=10)...

Read More

VeriTAS: Study Design and Baseline Characteristics for a Combination Therapy Trial in Wet AMD

Peter K. Kaiser, MD (Cleveland, OH)* PURPOSE: The VeriTAS study is designed to evaluate the efficacy and safety of verteporfin PDT combined with either intravitreal triamcinolone acetonide or pegaptanib sodium to treat subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD). The 24-month randomized, double-masked VeriTAS study enrolled patients at 50 centers in the U.S. METHODS: Inclusion criteria:...

Read More

Comparison Between Intravitreal Triamcinolone and Bevacizumab for Serous Ped and Occult Choroidal Neovascularization Secondary to AMD

David Hauser, MD (Kefar Bilu B, Israel), Yoel Greenvald, MD (Rehovot, Israel), Amir Bukelman, MD (Rehovot, Israel), Haya Katz, MD (Rehovot, Israel), Reut Parnes, MD (Rehovot, Israel), Nir Shoham, (Rehovot, Israel), Genady Landa, MD (Rehovot, Israel), Ayala Pollack, MD (Rehovot, Israel) PURPOSE: To compare the outcome of intravitreal triamcinolone (Kenalog) and intravitreal bevacizumab (Avastin) for eyes with serous PED and occult choroidal...

Read More

Prolonged Choroidal Hypofluorescence Following Verteporfin PDT Combined with Intravitreal Triamcinolone Acetate Injection for Agerelated CNVM

http://www.evrs.eu/medias/2006/congress/Prolonged-Choroidal-Hypofluorescence-Following-Verteporfin-PDT-Combined-with-Intravitreal-Triamcinolone-Acetate-Injection-for-Agerelated-CNVM.swf Jeffrey K. Luttrull, MD (Ventura, CA), Charles A Spink, CRA (Ventura, CA) PURPOSE: To determine the incidence and effect of prolonged choroidal hypofluorescence (PCH) following combined verteporfin photodynamic therapy and intravitreal triamcinolone acetate...

Read More

Sequential Pegaptanib Monotherapy Following Verteporfin Photodynamic Therapy for Choroidal Neovascularization

Paul B. Griggs, MD (Seattle, WA), Richard C. Lee, BS (Seattle, WA) PURPOSE: To review the clinical results of sequential pegaptanib monotherapy following verteporfin photodynamic therapy for choroidal neovascularization. METHODS: Patients were identified in which pegaptanib therapy was initiated following initial treatment of choroidal neovascularization with verteporfin photodynamic therapy with or without adjuvant intravitreal...

Read More

Comparison of Photodynamic Therapy Combined with Immediate Versus Delayed Intravitreal Triamcinolone Acetonide for Choroidal Neovascularization

Ajay Dudani, MD (Mumbai, India), Alay S Banker, MD (Ahmedabad, Gujarat, India), J. Fernando Arevalo, MD, FACS (Caracas, Venezuela) PURPOSE: To examine the 12-month results of a group of patients treated with combined photodynamic therapy (PDT) with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization (CNV). METHODS: Retrospective analysis of noncomparative case series of 54 eyes with CNV which were treated...

Read More

Intravitreally Injected Anti-VEGF Drugs Exert a Biological Effect in the Fellow Eye

http://www.evrs.eu/medias/2006/congress/Intravitreally-Injected-Anti-VEGF-Drugs-Exert-a-Biological-Effect-in-the-Fellow-Eye.swf Tongalp H. Tezel, MD (Louisville, KY), Charles C. Barr, MD (Louisville, KY), Henry J. Kaplan, MD (Louisville, KY) PURPOSE: To determine whether the intravitreal injection of anti-VEGF drugs (Kenalog, Macugen, Avastin) exert any biological effect in the fellow eyes of patients with bilateral exudative...

Read More

The Value and Cost-effectiveness of Interventions for Subfoveal, Neovascular, Age-related Macular Degeneration (ARMD)

http://www.evrs.eu/medias/2006/congress/The-Value-and-Cost-effectiveness-of-Interventions-for-Subfoveal,-Neovascular,-Age-related-Macular-Degeneration-(ARMD).swf Melissa M. Brown, MD, MN, MBA (Flourtown, PA),* Gary C. Brown, MD, MBA (Wyndmoor, PA)* PURPOSE: To assess the value of interventions utilized for the treatment of subfoveal, neovascular, agerelated macular degeneration (ARMD) employing evidencebased data from clinical trials...

Read More

Vision Improvement with Combination Low-fluence Photodynamic Therapy (LFPDT) and Intravitreal Injection

Gregory R. Blaha, MD, PhD (Peabody, MA), Jeffrey L. Marx, MD (Peabody, MA)* PURPOSE: To report our experience with combination low-fluence PDT. METHODS: An IRB-approved, retrospective chart review of all patients receiving low-fluence (50% standard) PDT (LFPDT) at our institution was performed. RESULTS: Twenty five eyes of 24 patients received LFPDT. Two eyes did not receive combination therapy, two received Macugen (Pegaptanib,...

Read More

Triple Combination Therapy (Photodynamic Therapy with Intravitreal Bevacizumab and Subtenon Triamcinolone Acetonide) for Choroidal Neovascularization

Alay S. Banker, MD (Ahmedabad, India), J. Fernando Arevalo, MD, FACS (Caracas, Venezuela), Ajay Dudani, MD (Mumbai, India) PURPOSE: To determine the results of combination triple therapy for choroidal neovascularization (CNV). METHODS: Prospective pilot study of 11 consecutive eyes with new (previously untreated) CNV which were treated with photodynamic therapy (PDT) with visudyne along with intravitreal bevacizumab (1.25mg) and subtenon...

Read More
content top